Fig. 2From: Measles second dose vaccine utilization and associated factors among children aged 24–35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveysThe pooled prevalence of MCV2 utilization in Sub-Saharan African countriesBack to article page